The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Type I Interferon: Potential Therapeutic Target for Psoriasis?
Open accessAbstract
BACKGROUND: Psoriasis is an immune-mediated disease characterized by aberrant epidermal differentiation, surface scale formation, and marked cutaneous inflammation. To better understand the pathogenesis of this disease and identify potential mediators, we used whole genome array analysis to profile paired lesional and nonlesional psoriatic skin and skin from healthy donors. METHODOLOGY/PRINCIPAL FINDINGS: We observed robust overexpression of type I interferon (IFN)-inducible genes and genomic signatures that indicate T cell and dendritic cell infiltration in lesional skin. Up-regulation of mRNAs for IFN-alpha subtypes was observed in lesional skin compared with nonlesional skin. Enrichment of mature dendritic cells and 2 type I IFN-inducible proteins, STAT1 and ISG15, were observed in the majority of lesional skin biopsies. Concordant overexpression of IFN-gamma and TNF-alpha-inducible gene signatures occurred at the same disease sites. CONCLUSIONS/SIGNIFICANCE: Up-regulation of TNF-alpha and elevation of the TNF-alpha-inducible gene signature in lesional skin underscore the importance of this cytokine in psoriasis; these data describe a molecular basis for the therapeutic activity of anti-TNF-alpha agents. Furthermore, these findings implicate type I IFNs in the pathogenesis of psoriasis. Consistent and significant up-regulation of type I IFNs and their associated gene signatures in psoriatic skin suggest that type I IFNs may be potential therapeutic targets in psoriasis treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
IRF-7 is the master regulator of type-I interferon-dependent immune responses
Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., et al. (2005) · Nature · doi:10.1038/nature03464 · Cited by 2,245
Baechler, E. C., Batliwalla, F. M., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., Shark, K. B., Grande, W. J., Hughes, K. M., Kapur, V., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337679100 · Cited by 2,240
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., & Pascual, V. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021553 · Cited by 1,958
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862
Cella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia, A., & Colonna, M. (1999) · Nature Medicine · doi:10.1038/11360 · Cited by 1,737
IRF Family of Transcription Factors as Regulators of Host Defense
Taniguchi, T., Ogasawara, K., Takaoka, A., & Tanaka, N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.623 · Cited by 1,658
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
Theofilopoulos, A. N., Baccala, R., Beutler, B., & Kono, D. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115843 · Cited by 1,185
Plasmacytoid predendritic cells initiate psoriasis through interferon-α production
Nestle, F. O., Conrad, C., Tun-Kyi, A., Homey, B., Gombert, M., Boyman, O., Burg, G., Liu, Y.-J., & Gilliet, M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050500 · Cited by 1,124
Lee, E., Trepicchio, W. L., Oestreicher, J. L., Pittman, D., Wang, F., Chamian, F., Dhodapkar, M., & Krueger, J. G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20030451 · Cited by 899
Self-citationInterferon‐α/β–mediated innate immune mechanisms in dermatomyositis
Greenberg, S. A., Pinkus, J. L., Pinkus, G. S., Burleson, T., Sanoudou, D., Tawil, R., Barohn, R. J., Saperstein, D. S., Briemberg, H. R., Ericsson, M., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20464 · Cited by 621
The immunologic basis for the treatment of psoriasis with new biologic agents
Krueger, J. G. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.120568 · Cited by 600
Self-citationLebwohl, M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12954-6 · Cited by 548
Zhao, C., Denison, C., Huibregtse, J. M., Gygi, S., & Krug, R. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504754102 · Cited by 472
Gilliet, M., Conrad, C., Geiges, M., Cozzio, A., Thürlimann, W., Burg, G., Nestle, F. O., & Dummer, R. (2004) · Archives of Dermatology · doi:10.1001/archderm.140.12.1490 · Cited by 408
Båve, U., Nordmark, G., Lövgren, T., Rönnelid, J., Cajander, S., Eloranta, M., Alm, G. V., & Rönnblom, L. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20998 · Cited by 390
Harada, H., Willison, K., Sakakibara, J., Miyamoto, M., Fujita, T., & Taniguchi, T. (1990) · Cell · doi:10.1016/0092-8674(90)90163-9 · Cited by 368
Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis
Nomura, I., Gao, B., Boguniewicz, M., Darst, M. A., Travers, J. B., & Leung, D. Y. M. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.08.049 · Cited by 332
Zhou, X., Krueger, J. G., Kao, M.-C. J., Lee, E., Du, F., Menter, A., Wong, W. H., & Bowcock, A. M. (2003) · Physiological Genomics · doi:10.1152/physiolgenomics.00157.2002 · Cited by 295
Self-citationLew, W., Bowcock, A. M., & Krueger, J. G. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.03.006 · Cited by 284
Self-citationKauffman, C. L., Aria, N., Toichi, E., McCormick, T. S., Cooper, K. D., Gottlieb, A. B., Everitt, D. E., Frederick, B., Zhu, Y., Graham, M. A., et al. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23448.x · Cited by 279
Hida, S., Ogasawara, K., Sato, K., Abe, M., Takayanagi, H., Yokochi, T., Sato, T., Hirose, S., Shirai, T., Taki, S., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00064-9 · Cited by 251
Chamian, F., Lowes, M. A., Lin, S.-L., Lee, E., Kikuchi, T., Gilleaudeau, P., Sullivan-Whalen, M., Cardinale, I., Khatcherian, A., Novitskaya, I., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409569102 · Cited by 221
Self-citationBoniface, K., Diveu, C., Morel, F., Pedretti, N., Froger, J., Ravon, E., Garcia, M., Venereau, E., Preisser, L., Guignouard, E., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4615 · Cited by 199
Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors
Christensen, S. R., & Shlomchik, M. J. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2006.12.005 · Cited by 161
van der Fits, L., van der Wel, L. I., Laman, J. D., Prens, E. P., & Verschuren, M. C. M. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2003.22113.x · Cited by 132
Analysis of Functional Domains of Interferon Regulatory Factor 7 and Its Association with IRF-3
Au, W.-C., Yeow, W.-S., & Pitha, P. M. (2001) · Virology · doi:10.1006/viro.2000.0782 · Cited by 100
Increased Sensitivity to Interferon-α in Psoriatic T Cells
Eriksen, K. W., Lovato, P., Skov, L., Krejsgaard, T., Kaltoft, K., Geisler, C., & Ødum, N. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23864.x · Cited by 85
Chamian, F., & Krueger, J. G. (2004) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000129715.35024.50 · Cited by 76
Self-citationDefining Upstream Elements of Psoriasis Pathogenesis: An Emerging Role For Interferon α
Nestle, F. O., & Gilliet, M. F. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23923.x · Cited by 60
Exacerbation of psoriasis by interferon-alpha therapy for hepatitis C
Downs, A. M., & Dunnill, M. G. S. (2000) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2000.00655-4.x · Cited by 59
In situ localization of interferons in psoriatic lesions
Livden, J. K., Nilsen, R., Bjerke, J. R., & Matre, R. (1989) · Archives of Dermatological Research · doi:10.1007/bf00455323 · Cited by 53
Cited by
Nestle, F. O., Kaplan, D. H., & Barker, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804595 · Cited by 2,786
Chiricozzi, A., Guttman-Yassky, E., Suárez-Fariñas, M., Nograles, K. E., Tian, S., Cardinale, I., Chimenti, S., & Krueger, J. G. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.340 · Cited by 686
Self-citationThe immunogenetics of Psoriasis: A comprehensive review
Harden, J. L., Krueger, J. G., & Bowcock, A. M. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.07.008 · Cited by 616
Self-citationThe IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses
Lowes, M. A., Russell, C. B., Martin, D. A., Towne, J. E., & Krueger, J. G. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.11.005 · Cited by 537
Self-citationThe Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings
Martin, D. A., Towne, J. E., Kricorian, G., Klekotka, P., Gudjonsson, J. E., Krueger, J. G., & Russell, C. B. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.194 · Cited by 466
Self-citation
Metadata
- Authors
- Yao, Y., Richman, L., Morehouse, C., de los Reyes, M., Higgs, B. W., Boutrin, A., White, B., Coyle, A., Krueger, J., Kiener, P. A., & Jallal, B.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-07-16
- Volume
- 3
- Issue
- 7
- Pages
- e2737
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2132041082
- Cited by
- 308
- References
- 32
- FWCI
- 5.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.